The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Dan Sindelar, DMD

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will review the impact of periodontal disease on metabolic and cardiovascular disease.

Learning Objectives

  1. Overview of periodontal disease and oral inflammation
  2. The underlying factors of Periodontal disease that affect cardiovascular risk through systemic inflammation
  3. Overview of current ways to reduce your patient’s cardiovascular risk with a team approach to disease management.

Disclosures
N/A

This enduring material activity, The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Margo Minissian, PhD, ACNP, FNLA, FAHA

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webinar will review adverse pregnancy outcomes women can encounter and how these can influence cardiovascular risk.

Learning Objectives

  1. Explain why adverse pregnancy outcomes (APOs) are important for heart disease prevention.
  2. Describe the types of adverse pregnancy outcomes that predispose women to increased cardiovascular risk
  3. Discuss heat-healthy lifestyle interventions for women with a history of an adverse pregnancy outcome.

Disclosures
Grant Funding (>$10,000): National Institute for Nursing Research, Beta Chi Chapter, Cedars-Sinai Precision Health Institute, National Institute of Heath Foundation/Ogilvy, National Institute of Nursing Research, Preventive Cardiovascular Nurses Association/American Nurses Foundation

Honorarium ($5,000): NACCME (LLC Co-Chair for CME and consultant), Amgen (Consultant, Medical Advisory Board), Vox Media, Medtelligence

This enduring material activity, The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Identifying Subclinical Cardiovascular Disease

Identifying Subclinical Cardiovascular Disease

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

 

Speaker Name/Credentials

Gina Pritchard, MSN, RN, CNS, ACNP

The PREVENT! Clinic, Plano, TX – Owner/Nurse Practitioner

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min Q&A = 0.25 credits

Total = 1.00 credits

Description

This webinar will cover current imaging methods that diagnose cardiovascular disease and biomarkers for the identification of cardiovascular disease.

Learning Objectives

  1. Understand and compare current imaging methodologies to diagnose cardiovascular disease
  2. Understand methods that identify subclinical cardiovascular disease
  3. Explore methods combining results of subclinical disease with biological testing to diagnose and treat patients to prevent disease progression

Disclosures

Speaker – Bale/Doneen Method, Bale/Doneen Practice, Cleveland HeartLab

This enduring material activity, Identifying Subclinical Cardiovascular Disease, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.